Trulieve reports Q3 2026 revenue of $230M
Trulieve reported milestone regulatory approval and strong Q3 2026 results, with higher margins and free cash flow meeting market expectations for a resilient medical cannabis platform.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed